Generics Makers Seek To Sell Drugs Below Wholesale To India’s Poor
This article was originally published in PharmAsia News
Executive Summary
Indian generics makers are pressing their government to be included as suppliers of drugs included in a national program to make low-cost drugs available to the poor. The program, Jan Aushadhi, consists of a drugstore chain able to negotiate with drug makers to provide drug prices well below wholesale. The Department of Pharmaceuticals is considering a list of firms willing to be suppliers, include 76 generics makers to date. Jan Aushadhi plans to announce soon the drugs it will supply, currently numbering 400. (Click here for more
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.